UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2023		99,895,473
Beginning balance at Dec. 31, 2023	$ 589,609	$ 100	$ (98,258)	$ 906,153	$ (239,729)		$ 21,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income including noncontrolling interests in subsidiaries	(34,698)				(36,057)		1,359
Other comprehensive income	(1,180)					$ (1,180)
Contributions from noncontrolling interests in subsidiaries	15,250						15,250
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)		0
Change in ownership percentage in subsidiary	0	$ 0		158			(158)
Stock options exercised (in shares)		61,667
Stock options exercised	223			223
Issuance of common stock for vesting of restricted stock units (in shares)		657,515
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		20,081
Shares withheld related to net share settlement of share-based awards (in shares)		(227,376)
Shares withheld related to net share settlement of share-based awards	(1,092)			(1,092)
Compensation expense for share-based awards	4,795			4,795
Ending balance (in shares) at Dec. 31, 2024		96,048,999
Ending balance at Dec. 31, 2024	552,619	$ 96	(118,542)	910,237	(275,786)	(1,180)	37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(4,358,361)
Repurchase of common stock	(20,288)	$ (4)	(20,284)
Net (loss) income including noncontrolling interests in subsidiaries	24,470				21,682		2,788
Other comprehensive income	1,850					1,850
Stock options exercised (in shares)		8,333
Stock options exercised	30			30
Issuance of common stock for vesting of restricted stock units (in shares)		524,208
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		69,531
Shares withheld related to net share settlement of share-based awards (in shares)		(175,602)
Shares withheld related to net share settlement of share-based awards	(675)			(675)
Compensation expense for share-based awards	5,738			5,738
Ending balance (in shares) at Dec. 31, 2025		96,475,469
Ending balance at Dec. 31, 2025	$ 584,032	$ 96	$ (118,542)	$ 915,330	$ (254,104)	$ 670	$ 40,582